NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 47 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $30,000 | -37.5% | 46,999 | 0.0% | 0.01% | -28.6% |
| Q2 2022 | $48,000 | -45.5% | 46,999 | 0.0% | 0.01% | -41.7% |
| Q1 2022 | $88,000 | -61.2% | 46,999 | 0.0% | 0.01% | -58.6% |
| Q4 2021 | $227,000 | -33.2% | 46,999 | 0.0% | 0.03% | -39.6% |
| Q3 2021 | $340,000 | -21.7% | 46,999 | 0.0% | 0.05% | -25.0% |
| Q2 2021 | $434,000 | -25.0% | 46,999 | 0.0% | 0.06% | -32.6% |
| Q1 2021 | $579,000 | -56.3% | 46,999 | -50.0% | 0.10% | -17.4% |
| Q4 2020 | $1,326,000 | – | 93,998 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,047,300 | $5,048,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 212,500 | $1,024,000 | 0.74% |
| Redmile Group, LLC | 3,490,835 | $16,826,000 | 0.38% |
| Kynam Capital Management, LP | 147,000 | $709,000 | 0.38% |
| EcoR1 Capital, LLC | 860,619 | $4,148,000 | 0.13% |
| Baker Brothers Advisors | 3,821,740 | $18,421,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 130,899 | $631,000 | 0.08% |
| Sio Capital Management, LLC | 38,312 | $185,000 | 0.06% |
| Highland Private Wealth Management | 46,999 | $227,000 | 0.03% |
| XTX Topco Ltd | 10,018 | $48,000 | 0.03% |